Page 26 - Vaccine

Two doses of Covid-19 vaccine give 98% protection, says PGI study

The study, which didn't spe­cify the name of the vacc­ine, was conducted on Pun­jab police personnel

Covid-19 vaccine estimate of 2 bn doses aspirational, optimistic: Govt

Inoculation drive is a marathon, not a 100-metre sprint, says health ministry

World's 'first' DNA vaccine against coronavirus: All you need to know

If things go well, ZyCoV-D could be the first approved vaccine for adolescents. The vaccine also works against the Delta variant, claims the company

Covovax denied trials on children; no nod needed for Sputnik Light

The decision comes as a setback to SII, which had sought permission to start a pediatric clinical trial of Covovax

Decoded: Why Brazilian govt is under scrutiny over Bharat Biotech vaccine

The Brazilian media has reported that though Bharat Biotech initially quoted a price of $1.34 per dose, the Brazilian govt agreed to pay $15 per shot, having ignored Pfizer's offer at a lower price

Brazil suspends $324-mn Covid-19 vaccine deal with Bharat Biotech

The deal to buy 20 million doses of Bharat Biotech's Covaxin shot has become a headache for Bolsonaro after whistleblowers went public with alleged irregularities

Top headlines: India approves Moderna vaccine; Sebi announces reforms

Business Standard brings you the top news of the evening

Sanofi to invest 400 million euros in mRNA vaccines development

The mRNA technology has proven both effective and safe so far in the vaccine response to COVID-19, including in response to the virus' variants.

Covid-19 vaccination: Fear, myths & rumours inject vaccine hesitancy

Govts, NGOs and corporations try to get fence-sitters to take the jab

Odisha govt to launch Pneumococcal Conjugate Vaccine on June 30

The Odisha Government on Thursday said that it will launch Pneumococcal Conjugate Vaccine (PCV) under the universal immunisation programme on June 30."The introduction of PCV in the routine immunization will benefit nearly 8 lakh young children annually in the State and it will help in reducing the risk of morbidity and mortality due to pneumonia and meningitis among children in the State", said the additional Chief Secretary PK Mohapatra in a letter to district and municipal authorities."Inviting in reference to the subject cited above, I am to say that Minister, Health & Family Welfare will launch Pneumococcal Conjugate Vaccine (PCV) under Universal Immunization Programme on 30th June 2021 at 11.30 AM at State level through virtual mode. After the introduction of PCV in the Routine Immunization, it will benefit nearly 8 lakh young children annually in our State and this will help in reducing risk of morbidity & mortality due to Pneumonia and meningitis among children in .

A jab at veracity

States should not aim to artificially push vaccination numbers

Bharat Biotech's Covaxin shows over 77% efficacy in phase 3 trials

The vaccine has shown an efficacy rate of 93 per cent against severe disease and 60 per cent against asymptomatic Covid-19

Coronavirus LIVE: Record 1.32 million vaccinated in a single day in Andhra

Coronavirus unlock live updates: India on Sunday reported 58,419 new Covid-19 cases and 1,576 deaths from the disease. Stay tuned for corona-related updates.

Sputnik V Covid vaccine roll out delayed for some days in Delhi: Official

An official had earlier said the hospital would start giving Sputnik V jabs by June 20

Over 29.10 crore Covid vaccine doses provided to States/UTs: Centre

More than 3.06 crore (3,06,34,638) Covid vaccine doses are still available with the States/UTs to be administered.

Russia continues working on new vaccines, medication for Covid: Putin

Putin added that Russian medical workers will continue getting special compensation for their work amid the coronavirus pandemic

Eyes on the world: Veteran lensman Raghu Rai talks about the digital age

Also discusses keeping a record of history and why his camera is not aimed at the pandemic

How Biological E could emerge as game changer in India's vaccine race

Company scales up its ambition after government advanced it Rs 1,500 crore for 300 million doses of its vaccine candidate.

Sustainable pricing

Govt and vaccine makers should be transparent

Covid-19 vaccine Covaxin at Rs 150 not sustainable: Bharat Biotech

Higher price in private market required to offset part of the costs, argues firm